Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections

Clinical trial NCT06731790 · COMPLETED

Trial details

NCT number: NCT06731790
Sponsor: University Hospital, Montpellier
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Rare Genetic Disease Acute Necrotizing Encephalopathy

Start date: 2025-04-24
Primary completion: 2025-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.